stockrowPrime Medicine, Inc. (PRME) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Prime Medicine, Inc. PRME 4.61 +3.60%
- Syndax Pharmaceuticals, Inc. SNDX 9.54 +1.81%
Prime Medicine, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Prime Medicine, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($843.6M and $807.1M). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 159.5% against −17.9%. Syndax Pharmaceuticals, Inc. has the higher net margin (−72.4% vs −4,613.1%) and the lower return on invested capital (−83.4% vs 0.00%). Across the 16 metrics below, Syndax Pharmaceuticals, Inc. leads on 10 and Prime Medicine, Inc. on 6.
Valuation
Profitability
| Metric | PRME | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.21% | 68.51% |
| Operating margin | (4,824.94%) | (61.72%) | 0.00% |
| Net margin | (4,613.11%) | (72.38%) | 0.00% |
| Free cash flow margin | (3,850.92%) | (61.36%) | 0.00% |
| Return on equity | (373.29%) | (426.43%) | (51.96%) |
| Return on assets | (71.16%) | (33.67%) | (46.06%) |
| Return on invested capital | 0.00% | (83.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack